F-18 PET/CT-Guided Lu-177 Therapy Added to Corticosteroid Injections for Chronic Plantar Fasciitis
Official title: F-18 Sodium Fluoride PET/CT-Guided Pain Palliation in Chronic Plantar Fasciitis: A Comparative Study of ¹⁷⁷Lutetium-Corticosteroid-Local Anaesthetic Injection vs Corticosteroid-Local Anaesthetic Injection
Run by Post Graduate Institute of Medical Education and Research, Chandigarh · NCT07907250 · Data updated 2026-11-12
This study tests whether adding a low-dose Lu-177 therapy guided by F-18 NaF PET/CT to standard corticosteroid injections helps relieve pain and improve function in adults with chronic plantar fasciitis who didn’t improve with conservative care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Post Graduate Institute of Medical Education and Research, Chandigarh Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Chandigarh, Chandigarh) |
| Status | Recruiting |
| Started | January 1, 2026 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT07907250 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with chronic plantar fasciitis (>6 months) who failed conservative therapy and meet PET/CT criteria for focal plantar fascia uptake.
✕Probably not a fit
Patients without focal uptake on F-18 NaF PET/CT or with contraindications to the study injections may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, randomized pilot trial comparing two intralesional treatment strategies for chronic plantar fasciitis. Participants aged 18–80 with at least six months of heel pain, a baseline pain score of 4 or higher, and focal uptake on F-18 NaF PET/CT are eligible. Forty participants will be enrolled, with 20 in each arm: one group receives F-18 NaF PET/CT-guided Lutetium-177 corticosteroid and local anesthetic injections, the other receives F-18 NaF PET/CT-guided corticosteroid and local anesthetic injections alone. Primary outcomes assess changes in foot pain and function, using the designated regional measures. The study aims to determine if the Lu-177–based addition offers superior pain relief and functional gains compared with corticosteroid injections alone.
Why it matters
Potential benefit: If successful, patients could experience greater pain relief and better functional ability with a targeted, image-guided intralesional therapy.
How similar studies have gone: Prior approaches using targeted, PET/CT-guided injections have shown potential in other musculoskeletal conditions, but this specific Lu-177 plus corticosteroid strategy for plantar fasciitis is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18-80 years with chronic plantar fasciitis (\>6 months). 2. Failed to conservative therapy. 3. Baseline VAS ≥4. 4. Focal uptake at plantar fascia insertion on F-18 NaF PET/CT. Exclusion Criteria: 1. Prior radiation therapy to the foot/heel. 2. Active infection at the injection site or systemic infection. 3. Pregnancy or lactation. (Pregnancy test for women of childbearing potential.) 4. Coagulopathy (INR \>1.5 or platelets \<100,000/µL) is not correctable. 5. Uncontrolled diabetes or severe peripheral vascular disease affecting wound healing. 6. Known allergy to agents would be used for local anaesthesia or to any component of the injection.
Where it's running
-
Postgraduate Institute of Medical Education and Research, Chandigarh
Chandigarh, Chandigarh, India Recruiting
Study contacts
- Study coordinator: Rajender Kumar
- Email: drrajender2010@gmail.com
- Phone: +91 9216605341
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulsed radiofrequency vs. 5% dextrose injection for chronic plantar fasciitis
This study tests whether ultrasound-guided pulsed radiofrequency or ultrasound-guided 5% dextrose injections help adults with long-lasting plantar fasciitis who haven’t improved with basic care.
-
Video-guided vs physician-led exercise training for plantar fasciitis
This trial tests whether a standardized video-based exercise program works as well as in-person instruction by a physician for adults with plantar fasciitis.
-
Deep transverse friction massage versus instrument-assisted soft tissue mobilization for pregnancy-related plantar fasciitis
This test compares deep transverse friction massage and instrument-assisted soft tissue mobilization to see which better reduces heel pain and improves walking for pregnant women with plantar fasciitis.
-
Dissolvable SakuraBead embolization for plantar fascia pain
This trial will try dissolvable SakuraBead embolization in adults with plantar fasciitis to see if it reduces heel pain better than shockwave therapy.
-
Effects of dry needling combined with physical therapy on plantar fasciitis
This study is testing if combining dry needling with regular physical therapy can help people aged 40-60 with chronic heel pain feel better and move more easily compared to just doing physical therapy alone.
-
Comparing IASTM and Kinesiotaping for Plantar Fasciitis
This study is testing whether a hands-on treatment called IASTM or a supportive taping method works better to help people aged 20-40 with chronic heel pain from plantar fasciitis feel better and improve their foot function.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.